医学信息
醫學信息
의학신식
MEDICAL INFORMATION
2014年
32期
16-17
,共2页
潘博%潘敏求%黎月恒%李东芳%李琳霈
潘博%潘敏求%黎月恆%李東芳%李琳霈
반박%반민구%려월항%리동방%리림패
肺癌养阴清解法则肺复方中药治疗临床对照研究
肺癌養陰清解法則肺複方中藥治療臨床對照研究
폐암양음청해법칙폐복방중약치료림상대조연구
Lung cancer%Nourishing yin and clearing method%Lung compound prescription%Chinese medicine treatment%Clinical and experimental study
目的:主要对照观察养阴清解法则与化瘀清解法则治疗肺癌的临床疗效。方法采用单盲随机对照方法,对符合纳入标准的原发性非小细胞肺癌80例,分为治疗组(养阴清解法则组成的"肺复方组")与对照组(化瘀清解法则组成的"化瘀方组")各40例进行对照研究,1个月为1疗程,连续治疗2疗程,观察并随访记录两组临床症状,瘤体疗效、疾病进展时间,中位生存期,生存率及生活质量、体重等变化情况。结果临床研究瘤体有效率(CR+PR)治疗组15.00%,明显高于对照组7.50%(P<0.05),瘤体稳定率(CR+PR+SD)治疗组87.50%,明显高于对照组67.50%(P<0.05)。疾病进展时间(TTP)治疗组6.6月,对照组5.4月。中位生存期(MST)治疗组13.6月,对照组11.4月;1年、2年生存率治疗组分别为77.50%、55.00%,高于对照组60.00%、40.00%,(P<0.05);临床症状总有效率,治疗组87.50%高于对照组67.00%,(P<0.05);同时生活质量改善、体重改善,治疗组均优于对照组(P<0.05)。结论养阴清解法则(该法则组成的"肺复方")具有益气养阴、清热解毒之功,作为基本法则治疗肺癌,十分切合肺癌的病因病机,具有改善肺癌患者临床症状,提高生活质量,抑制、稳定瘤体,提高机体免疫功能,延缓疾病进展,延长生存期的作用均优于化瘀清解法则。提示养阴清解法则及该法则组成的肺复方是治疗肺癌的有效治则和方药。
目的:主要對照觀察養陰清解法則與化瘀清解法則治療肺癌的臨床療效。方法採用單盲隨機對照方法,對符閤納入標準的原髮性非小細胞肺癌80例,分為治療組(養陰清解法則組成的"肺複方組")與對照組(化瘀清解法則組成的"化瘀方組")各40例進行對照研究,1箇月為1療程,連續治療2療程,觀察併隨訪記錄兩組臨床癥狀,瘤體療效、疾病進展時間,中位生存期,生存率及生活質量、體重等變化情況。結果臨床研究瘤體有效率(CR+PR)治療組15.00%,明顯高于對照組7.50%(P<0.05),瘤體穩定率(CR+PR+SD)治療組87.50%,明顯高于對照組67.50%(P<0.05)。疾病進展時間(TTP)治療組6.6月,對照組5.4月。中位生存期(MST)治療組13.6月,對照組11.4月;1年、2年生存率治療組分彆為77.50%、55.00%,高于對照組60.00%、40.00%,(P<0.05);臨床癥狀總有效率,治療組87.50%高于對照組67.00%,(P<0.05);同時生活質量改善、體重改善,治療組均優于對照組(P<0.05)。結論養陰清解法則(該法則組成的"肺複方")具有益氣養陰、清熱解毒之功,作為基本法則治療肺癌,十分切閤肺癌的病因病機,具有改善肺癌患者臨床癥狀,提高生活質量,抑製、穩定瘤體,提高機體免疫功能,延緩疾病進展,延長生存期的作用均優于化瘀清解法則。提示養陰清解法則及該法則組成的肺複方是治療肺癌的有效治則和方藥。
목적:주요대조관찰양음청해법칙여화어청해법칙치료폐암적림상료효。방법채용단맹수궤대조방법,대부합납입표준적원발성비소세포폐암80례,분위치료조(양음청해법칙조성적"폐복방조")여대조조(화어청해법칙조성적"화어방조")각40례진행대조연구,1개월위1료정,련속치료2료정,관찰병수방기록량조림상증상,류체료효、질병진전시간,중위생존기,생존솔급생활질량、체중등변화정황。결과림상연구류체유효솔(CR+PR)치료조15.00%,명현고우대조조7.50%(P<0.05),류체은정솔(CR+PR+SD)치료조87.50%,명현고우대조조67.50%(P<0.05)。질병진전시간(TTP)치료조6.6월,대조조5.4월。중위생존기(MST)치료조13.6월,대조조11.4월;1년、2년생존솔치료조분별위77.50%、55.00%,고우대조조60.00%、40.00%,(P<0.05);림상증상총유효솔,치료조87.50%고우대조조67.00%,(P<0.05);동시생활질량개선、체중개선,치료조균우우대조조(P<0.05)。결론양음청해법칙(해법칙조성적"폐복방")구유익기양음、청열해독지공,작위기본법칙치료폐암,십분절합폐암적병인병궤,구유개선폐암환자림상증상,제고생활질량,억제、은정류체,제고궤체면역공능,연완질병진전,연장생존기적작용균우우화어청해법칙。제시양음청해법칙급해법칙조성적폐복방시치료폐암적유효치칙화방약。
Objective To observe the clinical therapeutic ef ects of Nourishing yin and clearing method for non-smal celllung cancer. Methods By using randomized single blind control ed method,80 cases of patient were selected according to the selecting standard and divided into experimental group and control group randomly which both had 40 cases respectively.One month a course of treatment.Clinical symptoms,tumor state,time to disease progression,median survival time,survival rate and quality of life,weight were observed and recorded in two courses of treatment.Animal experimental study on the antitumor ef ect and improve immune function was done as wel .Results Clinical study The tumor with ef iciency (CR+PR)the treatment group was 15.00%,significantly higher than control group 7.50%( P<0.05).The tumor body stable rate (CR+PR+SD)the treatment group was 87.50%,significantly higher than control group67.50%( P<0.05).TTP the treatment group was 6.6months,the control group was 5.4months.The one year and tow year survival rate were 77.50%、55.00%respectively,higher than control group 60%、40.00%( P<0.05).The total ef iciency of clinical ef ective the treatment group was 87.50%,higher than control group 67.00%( P<0.05).Experimental group’s quality of life and weight were also improved significantly.Conclusion Nourishing yin and clearing method has the function of supplementing qi and nourishing Yin,clearing heat and detoxification.As the basic rule in the treatment of lung cancer is very suitable for the etiology and pathogenesis of lung cancer.Nourishing yin and clearing method can significantly relieve the main clinical symptoms,increase the quality of life,restrain and stabilize tumor size,improve immune function,delay the progression of the disease,prolong the survival period which were confirmed in clinical and experimental study.Prompt that nourishing yin and clearing method and lung compound prescription is ef ective therapy and prescription for treatment of lung cancer.